1. Home
  2. ENTX vs AIRG Comparison

ENTX vs AIRG Comparison

Compare ENTX & AIRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENTX
  • AIRG
  • Stock Information
  • Founded
  • ENTX 2010
  • AIRG 1995
  • Country
  • ENTX Israel
  • AIRG United States
  • Employees
  • ENTX N/A
  • AIRG N/A
  • Industry
  • ENTX Biotechnology: Biological Products (No Diagnostic Substances)
  • AIRG Radio And Television Broadcasting And Communications Equipment
  • Sector
  • ENTX Health Care
  • AIRG Technology
  • Exchange
  • ENTX Nasdaq
  • AIRG Nasdaq
  • Market Cap
  • ENTX 90.2M
  • AIRG 79.4M
  • IPO Year
  • ENTX 2018
  • AIRG 2016
  • Fundamental
  • Price
  • ENTX $2.43
  • AIRG $7.15
  • Analyst Decision
  • ENTX Strong Buy
  • AIRG Strong Buy
  • Analyst Count
  • ENTX 1
  • AIRG 2
  • Target Price
  • ENTX $10.00
  • AIRG $11.75
  • AVG Volume (30 Days)
  • ENTX 83.2K
  • AIRG 27.1K
  • Earning Date
  • ENTX 03-07-2025
  • AIRG 02-27-2025
  • Dividend Yield
  • ENTX N/A
  • AIRG N/A
  • EPS Growth
  • ENTX N/A
  • AIRG N/A
  • EPS
  • ENTX N/A
  • AIRG N/A
  • Revenue
  • ENTX $99,000.00
  • AIRG $55,586,000.00
  • Revenue This Year
  • ENTX N/A
  • AIRG $13.03
  • Revenue Next Year
  • ENTX N/A
  • AIRG $12.35
  • P/E Ratio
  • ENTX N/A
  • AIRG N/A
  • Revenue Growth
  • ENTX 607.14
  • AIRG N/A
  • 52 Week Low
  • ENTX $0.95
  • AIRG $3.71
  • 52 Week High
  • ENTX $3.35
  • AIRG $10.34
  • Technical
  • Relative Strength Index (RSI)
  • ENTX 54.06
  • AIRG 48.93
  • Support Level
  • ENTX $2.21
  • AIRG $6.85
  • Resistance Level
  • ENTX $2.62
  • AIRG $7.23
  • Average True Range (ATR)
  • ENTX 0.21
  • AIRG 0.39
  • MACD
  • ENTX -0.01
  • AIRG 0.03
  • Stochastic Oscillator
  • ENTX 69.35
  • AIRG 60.36

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

About AIRG Airgain Inc.

Airgain Inc is engaged in providing antenna technologies. These technologies can be used to enable performance wireless networking across devices and markets which include connected homes, enterprises, automotive, and the Internet of Things. It also provides solutions to complex radio frequency, engineering challenges, and improving wireless service that require higher throughput, broad coverage footprint, and carrier-grade quality. Geographically, it derives maximum revenue from North America and also has a presence in China and the Rest of the World. The company products include Antenna Plus: Fleet, M2M, IoT Antennas, Carrier-Class Antenna, Embedded Antennas, and External Dipole Antennas.

Share on Social Networks: